RE:Shorting is this stocks major problemHi Twiggy,
i bought my shares last spring and should have sold at $33 but got greedy and decided to wait. There was so much promise back then and other OWS companies got big funding. Then came the peer review that should have been done in July or August as implied by Dr Kim. It never happened and the e shares tanked. Then it was supposed to happen soon and it never happened as promised. The FDA shuts it all down over the Cellectra device. THIS COMPANY got what it deserved and until they get a business man instead of a doctor to run this properly and do real PR's , this is as good as it gets